It was found that RAGE blockade could relieve tubular and glomerular damage resulting from diabetes as well as glomerulosclerosis induced by adriamycin (Guo et al., 2008; Matsui et al., 2017; Sanajou et al., 2019). This evidence concerns the gene AGER and glomerulosclerosis.